Spine Metastasis
Conditions
Keywords
spine metastasis, SBRT, Radiosurgery
Brief summary
Demonstrate the technical feasibility of treating spine metastases with image-guided radiosurgery/SBRT
Interventions
RADIATIONSBRT
•24 Gy in 3 fractions to cover at least 90% of the defined target volume
RADIATIONRadiosurgery
16 Gy in 1 fraction to cover at least 90% of the defined target volume
Sponsors
Chinese University of Hong Kong
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. The patient must have localized spine metastasis from the C1 to L5 levels by a screening imaging study (bone scan, PET, CT, or MRI). A solitary spine metastasis; two separate spine levels; or up to 3 separate sites are permitted. Each of the separate sites may have a maximal involvement of 2 contiguous vertebral bodies. A paraspinal mass ≤ 5 cm is allowed. 2. Zubrod Performance Status 0-2; 3. Age ≥ 18; 4. History/physical examination within 2 weeks prior to registration; 5. No pregnancy for women of childbearing potential; 6. MRI of the involved spine within 4 weeks prior to registration to determine the extent of the spine involvement. MRI is required as it is superior to a CT scan in delineating the spinal cord as well as identifying an epidural or paraspinal soft tissue component. If possible, an MRI with thin slice thickness (\<1mm) with 3D reconstruction quality would be most preferable for treatment planning purpose. 7. Numerical Rating Pain Scale within 1 week prior to registration. The patient must have a score on the Scale of ≥ 4 for at least one of the planned sites for spine radiosurgery. Patients taking medication for pain at the time of registration are eligible. 8. Neurological examination within 1 week prior to registration to rule out rapid neurologic decline; see Appendix IV for the standardized neurological examination. Patients with mild to moderate neurological signs are eligible. These neurological signs include radiculopathy, dermatomal sensory change, and muscle strength of involved extremity 4/5 (lower extremity for ambulation or upper extremity for raising arms and/or arm function). 9. Patients with epidural compression are eligible provided that there is no significant displacement or compression on the spinal cord itself. 10. Patients with a paraspinal mass ≤ 5 cm in the greatest dimension and that is contiguous with spine metastasis are eligible. 11. Patients must provide study specific informed consent prior to study entry.
Exclusion criteria
1. Histologies of myeloma or lymphoma. 2. Patients with any spine metastasis with a rating of \< 4 on the Numerical Rating Pain Scale. 3. Non-ambulatory patients. 4. Spine instability due to a compression fracture. 5. \> 50% loss of vertebral body height. 6. Significant spinal cord compression or displacement. 7. Patients with rapid neurologic decline. 8. Bony retropulsion causing neurologic abnormality. 9. Prior radiation to the index spine. 10. Patients for whom an MRI of the spine is medically contraindicated.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain control at 3 months post-treatment | 4 years |
Secondary
| Measure | Time frame |
|---|---|
| Determine the duration of pain response at the treated site(s) using radiosurgery/SBRT | 4 years |
| Study the adverse events of radiosurgery/SBRT according to the criteria in the CTEP Active Version of the CTCAE | 4 years |
| Evaluate the radiological response of image-guided radiosurgery/SBRT by RECIST MRI | 4 years |
| Determine the time of onset of pain response of the responders at the treated site(s) using radiosurgery/SBRT | 4 years |
| Overall Survival | 4 years |
| Quality of life assessment | 4 years |
| 2-year Tumor Control Rate | 4 years |
Countries
Hong Kong
Outcome results
None listed